Newsletter | March 19, 2019

03.19.19 -- Cardiac Stem Cell Controversy: 3 Important Lessons Learned

 
Featured Editorial
Cardiac Stem Cell Controversy: 3 Important Lessons Learned
 
By Sarah Blunt, PA Consulting

Over the past 20 years, hope has grown around the use of stem cells to enhance regeneration following a heart attack, wherein stem cells would facilitate tissue repair and help restore heart muscle function. However, the legitimacy of cardiac stem cell research is now being called into question.

Industry Insights
Are You Under-Using And Under-Investing In Your Most Valuable Resource?
Article | Dassault Systemes Americas

Larger pharma organization have evolved into hierarchical silos due to a combination of legacy organizational structures, mergers and acquisitions, and lack of a holisitic approach to innovation.

Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.